MySize raises $2.5 million in private placement to fund growth and defense ambitions
Sep 15, 2026, 8:08 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Small-cap stock with new share issuance and warrants typically pressures per-share value in the near term due to dilution; the market will assess whether cash improves liquidity and supports expansion plans, especially given the company's pivot toward defense tech which may entail execution risk. Historical cases show modest initial negative re-pricing after dilutive financings, followed by longer-term recovery if deployment meets milestones.
AI summary
What happened, with direct paths to the underlying reporting
MySize disclosed a private placement to raise about $2.5 million by issuing 1,308,901 common shares (or pre-funded warrants) at $1.91, with accompanying Series C and D warrants. The funds will support general corporate needs, including working capital, and assist the company’s strategic move into defense technology through selective acquisitions. The deal introduces dilution and hinges on completing the sale and registering the securities, influencing near-term stock performance.
MySize to raise about $2.5M via private placement at $1.91 per share. Includes unregistered Series C and D warrants.
H.C. Wainwright is exclusive placement agent; closing expected around September 16, 2026.
Proceeds for general corporate purposes, including working capital; securities private and unregistered.
Warrants: Series C five-year term at $1.66; Series D 18 months; immediate exercisability.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
